SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For quarter ended December 31, 1994
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 0-14946
ARMOR ALL PRODUCTS CORPORATION
------------------------------------------------------
(Exact Name of Registrant as specified in its charter)
DELAWARE 33-0178217
- ------------------------------- -------------------
(State or other jurisdiction of (IRS Employer
incorporation or organization) Identification No.)
6 Liberty, Aliso Viejo, California 92656
------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(714) 362-0600
----------------------------------------------------
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None.
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 Par Value
-----------------------------
(Title of Class)
Indicate by check mark whether the Registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes [X] No [ ]
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.
Class Outstanding at December 31, 1994
- ----------------------------- --------------------------------
Common stock, $0.01 par value 21,234,785 Shares
The undersigned registrant hereby amends the items, financial
statements, exhibits or other portions of its Form 10-Q for the
quarter ended December 31, 1994 as set forth below.
LIST OF ITEMS AMENDED
---------------------
1. Amendment of Exhibit 27
TEXT OF AMENDMENTS
-------------------
1. Amendment of Exhibit 27
-----------------------
The purpose of this amendment is to properly file Exhibit 27.
Exhibit 27 is hereby amended by deleting the balance sheet in its
entirety and replacing it with Consolidated Balance Sheets attached
hereto and filed herewith.
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this amendment to be signed on
its behalf by the undersigned, thereunto duly authorized.
ARMOR ALL PRODUCTS CORPORATION
(Registrant)
Date: March 20, 1995 /s/Nancy A. Miller
-------------------------------
Nancy A. Miller
Vice President and Secretary
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
Exhibit (27)
ARMOR ALL PRODUCTS CORPORATION
FINANCIAL DATA SCHEDULE
December 31, 1994
(in millions except per share amounts)
This schedule contains summary financial information extracted from the Armor All
Products Corporation Consolidated Financial Statements as of December 31, 1994 and
March 31, 1994 and for the nine months ended December 31, 1994 and 1993 and is
qualified in its entirety by reference to such financial statements.
<CAPTION>
REGULATION
NUMBER STATEMENT CAPTION FY95 FY94
- ---------- ----------------- ------ ------
<S> <C> <C> <C>
5-02(1) Cash and cash items $ 44.4 $ 26.3
5-02(2) Marketable securities - -
5-02(3)(a)(1) Accounts receivable - trade 37.6 69.3
5-02(4) Allowance for doubtful accounts (1.4) (1.3)
5-02(6) Inventory 9.5 4.2
5-02(9) Total current assets 96.1 99.2
5-02(13) Property, plant and equipment 13.9 12.9
5-02(14) Accumulated depreciation (5.1) (4.2)
5-02(18) Total assets 147.1 151.8
5-02(21) Total current liabilities 24.3 34.9
5-02(22) Bonds, mortgages and similar debt - -
5-02(28) Preferred stock - mandatory redemption - -
5-02(29) Preferred stock - no mandatory redemption - -
5-02(30) Common stock 0.2 0.2
5-02(31) Other stockholders' equity 121.9 115.8
5-02(32) Total liabilities & stockholders' equity 147.1 151.8
5-03(b)(1)(a) Net sales of tangible products 136.9 117.4
5-03(b)(1) Total revenues 136.9 117.4
5-03(b)(2) Total costs & exp. appl. to sales & revenues 58.4 48.1
5-03(b)(3) Other costs and expenses - -
5-03(b)(5) Provision for doubtful accounts & notes 0.2 0.4
5-03(b)(8) Interest & amortization of debt discount - -
5-03(b)(10) Income before taxes & other items 25.9 23.1
5-03(b)(11) Income tax expense 11.0 10.0
5-03(b)(14) Income/loss from continuing operations - -
5-03(b)(15) Discontinued operations - -
5-03(b)(17) Extraordinary items - -
5-03(b)(18) Cumulative effect-chngs. in acctg. prin. - -
5-03(b)(19) Net income or loss 14.8 13.1
5-03(b)(20) Earnings per share - primary 0.70 0.62
5-03(b)(20) Earnings per share - fully diluted - -
</TABLE>
